ArticleJournal of microbiology (Seoul, Korea)2022

The novel antifungal agent AB-22 displays in vitro activity against hyphal growth and biofilm formation in Candida albicans and potency for treating systemic candidiasis.

Kyung-Tae Lee et al.PubMed ↗Publisher ↗

No numbers read from the abstract.